JAK2 and breast carcinoma: IL-1 upregulation involves leptin activation of JAK2/STAT, PKC, p38, MAPK/ERK1/2, PI-3K/AKT1 and JNK suggesting that multiple leptin-induced signaling pathways can affect leptin-IL-1 crosstalk in breast cancer [40].